Long-term cost-utility analysis of family therapy vs. treatment as usual for young people seen after self-harm

Bojke, Chris;Cottrell, David;Wright-Hugues, Alex;Farrin, Amanda;Tubeuf, Sandy
(2024) Cost Effectiveness and Resource Allocation — Vol. 22, n° 49, p. 1-13 (2024)

Files

Bojke_etal2024.pdf
  • Open Access
  • Adobe PDF
  • 1.5 MB

Details

Authors
  • Bojke, Chris
    Author
  • Cottrell, David
    Author
  • Wright-Hugues, Alex
    Author
  • Farrin, Amanda
    Author
  • Tubeuf, Sandyorcid-logoUCLouvain
    Author
Abstract
(en) Background The joint evidence of the cost and the effectiveness of family-based therapies is modest. Objective To study the cost-effectiveness of family therapy (FT) versus treatment-as-usual (TAU) for young people seen after self-harm combining data from an 18-month trial and hospital records up to 60-month from randomisation. Methods We estimate the cost-effectiveness of FT compared to TAU over 5 years using a quasi-Markov state model based on self-harm hospitalisations where probabilities of belonging in a state are directly estimated from hospital data. The primary outcome is quality-adjusted life years (QALY). Cost perspective is NHS and PSS and includes treatment costs, health care use, and hospital attendances whether it is for self-harm or not. Incremental cost-effectiveness ratios are calculated and deterministic and probabilistic sensitivity analyses are conducted. Results Both trial arms show a significant decrease in hospitalisations over the 60-month follow-up. In the base case scenario, FT participants incur higher costs (mean +£1,693) and negative incremental QALYs (-0.01) than TAU patients. The associated ICER at 5 years is dominated and the incremental health benefit at the £30,000 per QALY threshold is -0.067. Probabilistic Sensitivity Analysis finds the probability that FT is cost-effective is around 3 − 2% up to a maximum willingness to pay of £50,000 per QALY. This suggest that the extension of the data to 60 months show no difference in effectiveness between treatments. Conclusion Whilst extended trial follow-up from routinely collected statistics is useful to improve the modelling of longer-term cost-effectiveness, FT is not cost-effective relative to TAU and dominated in a cost-utility analysis.
Affiliations

Citations

Bojke, C., Cottrell, D., Wright-Hugues, A., Farrin, A., & Tubeuf, S. (2024). Long-term cost-utility analysis of family therapy vs. treatment as usual for young people seen after self-harm. Cost Effectiveness and Resource Allocation, 22(49), 1-13. https://doi.org/10.1186/s12962-024-00546-z (Original work published 2024)